Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Erlotinib | 3.1623 | uM | 9 | 625.00 | 186.95 | 191.00 | 3107.00 | 0.0615 | 0.0053 |
MCF 10A | 17-AAG | 0.31623 | uM | 9 | 625.00 | 186.95 | 130.00 | 3107.00 | 0.0418 | -0.0857 |
MCF 10A | Linsitinib | 19.9526 | uM | 9 | 625.00 | 186.95 | 277.00 | 3107.00 | 0.0892 | 0.1018 |
MCF 10A | Linsitinib | 0.01 | uM | 9 | 625.00 | 186.95 | 3567.00 | 3107.00 | 1.1481 | 1.0693 |
MCF 10A | Linsitinib | 0.031623 | uM | 9 | 625.00 | 186.95 | 3012.00 | 3107.00 | 0.9694 | 0.9847 |
MCF 10A | Lapatinib | 0.01 | uM | 9 | 625.00 | 186.95 | 3077.00 | 3107.00 | 0.9903 | 0.9952 |
MCF 10A | 17-AAG | 0.031623 | uM | 9 | 625.00 | 186.95 | 172.00 | 3107.00 | 0.0554 | -0.0204 |
MCF 10A | Lapatinib | 0.1 | uM | 9 | 625.00 | 186.95 | 3981.00 | 3107.00 | 1.2813 | 1.1261 |
MCF 10A | Erlotinib | 0.31623 | uM | 9 | 625.00 | 186.95 | 1836.00 | 3107.00 | 0.5909 | 0.7567 |
MCF 10A | Linsitinib | 0.31623 | uM | 9 | 625.00 | 186.95 | 2840.00 | 3107.00 | 0.9141 | 0.9562 |
MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 186.95 | 3267.00 | 3107.00 | 1.0515 | 1.0249 |
MCF 10A | 17-AAG | 0.01 | uM | 9 | 625.00 | 186.95 | 1804.00 | 3107.00 | 0.5806 | 0.7491 |
MCF 10A | Lapatinib | 0.031623 | uM | 9 | 625.00 | 186.95 | 2996.00 | 3107.00 | 0.9643 | 0.9821 |
MCF 10A | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 186.95 | 3000.00 | 3107.00 | 0.9656 | 0.9828 |
MCF 10A | 17-AAG | 0.1 | uM | 9 | 625.00 | 186.95 | 167.00 | 3107.00 | 0.0538 | -0.0275 |
MCF 10A | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 186.95 | 2860.00 | 3107.00 | 0.9205 | 0.9596 |
MCF 10A | Linsitinib | 3.1623 | uM | 9 | 625.00 | 186.95 | 855.00 | 3107.00 | 0.2752 | 0.4549 |
MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 186.95 | 3153.00 | 3107.00 | 1.0148 | 1.0073 |
MCF 10A | Lapatinib | 1 | uM | 9 | 625.00 | 186.95 | 2118.00 | 3107.00 | 0.6817 | 0.8197 |
MCF 10A | 0 | uM | 9 | 625.00 | 186.95 | 3176.00 | 3107.00 | 1.0222 | 1.0109 | |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 6212.00 | 6493.50 | 0.9567 | 0.9787 | |
MCF 10A | Linsitinib | 0.1 | uM | 9 | 1250.00 | 369.45 | 6341.00 | 6493.50 | 0.9765 | 0.9885 |
MCF 10A | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 369.45 | 4696.00 | 6493.50 | 0.7232 | 0.8493 |
MCF 10A | Linsitinib | 10 | uM | 9 | 1250.00 | 369.45 | 1730.00 | 6493.50 | 0.2664 | 0.4525 |
MCF 10A | Erlotinib | 0.1 | uM | 9 | 1250.00 | 369.45 | 6757.00 | 6493.50 | 1.0406 | 1.0193 |